A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Weill Cornell Medical College in Qatar
Abstract
A novel coronavirus, which has been designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and causes the highly infectious disease referred to as COVID-19. COVID-19 has now spread worldwide to become a global pandemic affecting over 24 million people as of August 26th, 2020 and claimed the life of more than 800,000 people worldwide. COVID-19 is asymptomatic for some individuals and for others it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS), pneumonia and death. Although it is anticipated that an effective vaccine will be available to protect against COVID-19, at present the world is relying on…
Citation impact
- FWCI
- 12.35
- Percentile
- 100%
- References
- 60
Authors
4Topics & keywords
- Medicine
- Pandemic
- Coronavirus disease 2019 (COVID-19)
- Intensive care medicine
- Clinical trial
- Pneumonia
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Vaccine efficacy
- Good health and well-being